CombiMatrix to Present at Upcoming Investor Conferences
22 Maggio 2017 - 12:00PM
CombiMatrix Corporation (NASDAQ:CBMX), a family health molecular
diagnostics company specializing in DNA-based reproductive health
and pediatric testing services, announces that management will
present at two upcoming investor conferences:
- B. Riley & Co.’s 18th Annual Investor Conference on
Thursday, May 25, at 11:00 a.m. Pacific time. The conference
is being held at the Loews Santa Monica Beach Hotel.
- 7th Annual LD Micro Invitational on Tuesday, June 6, at 3:00
p.m. Pacific time. The conference is being held at the Luxe
Sunset Boulevard Hotel in Los Angeles.
About CombiMatrix
Corporation
CombiMatrix Corporation provides sophisticated
molecular diagnostic solutions and comprehensive clinical support
to foster the highest quality in patient care. CombiMatrix
specializes in pre-implantation genetic diagnostics and screening,
prenatal diagnosis, miscarriage analysis and pediatric
developmental disorders, offering DNA-based testing for the
detection of genetic abnormalities beyond what can be identified
through traditional methodologies. Our testing focuses on advanced
technologies, including single nucleotide polymorphism chromosomal
microarray analysis, next generation sequencing, fluorescent in
situ hybridization and high resolution karyotyping. Additional
information about CombiMatrix is available at www.combimatrix.com
or by calling (800) 710-0624.
Company Contact: Mark McDonough President & CEO, CombiMatrix
Corporation(949) 753-0624
Investor Contact: LHA Jody Cain (310)
691-7100jcain@lhai.com
Grafico Azioni Combimatrix Corp. (MM) (NASDAQ:CBMX)
Storico
Da Mag 2024 a Giu 2024
Grafico Azioni Combimatrix Corp. (MM) (NASDAQ:CBMX)
Storico
Da Giu 2023 a Giu 2024
Notizie in Tempo Reale relative a Combimatrix Corp. (MM) (NASDAQ): 0 articoli recenti
Più Articoli Notizie